Probably the blandest reporting on DEP® docetaxel I have seen to date so that is a worry
IMO - Spin doctors at their best in this section below folks .... they make the company sound so "international" when they are nothing but a Speculative biotech running at a loss at the moment due to (IMO) incompetence ....
...... and as for this line "further DEP® partnerships are at an advanced stage of negotiation with leading pharmaceutical companies" - well I have seen the exact same rhetoric for years; It's always at "advanced stages" .... perhaps actually convert something and people's views might change ?
That's my take on the cut and past Shareholder Newsletter that I pointed out recently was 6 months in the making in the below post ... maybe Scotty from Marketing does actually read HC ? Enjoy your weekend SPL'ers
https://hotcopper.com.au/threads/patience.6767665/page-28?post_id=61759435#.YpmMP3ZBzIU
We used to get a Shareholder Newsletter a few times a year once too .... I noticed today that the last one we received was in December 2021 .... we are now 6 months into 2022 and not one has surfaced this year
